Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
Recruiting · NCT05917587 · Registry updated 2025-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes | Female Urogenital Diseases and Pregnancy Complications, Nutritional and Metabolic Diseases, Urogenital Diseases, diabetes mellitus, endocrine system disorder, gestational diabetes, glucose metabolism disease, metabolic disease, pregnancy disorder | Recruiting | Early phase 1 | 2025-05-13 | NCT05917587 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anna Stanhewicz, PhD | 12 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Iowa | Iowa City | United States | 284 |